Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MFZ 10-7 is a negative allosteric modulator (NAM) and inverse agonist of metabotropic glutamate receptor 5 (mGluR5).1 It selectively binds to mGluR5 (Ki = 0.67 nM) over a panel of 63 additional receptors and ion channels at 100 nM. MFZ 10-7 reduces D-myo-inositol 1 phosphate (1-IP1; Item No. 1000777) accumulation, a marker of D-myo-inositol-1,4,5-triphosphate (1,4,5-IP3; Item No. 10008205) production, in an ELISA-based immunocompetitive assay using HEK293A cells expressing rat mGluR5 (IC50 = 2.4 nM). In vivo, MFZ 10-7 (0.3 mg/kg) increases the number of transitions between the light and dark area in a light-dark exploration test, indicating anxiolytic-like activity, and increases locomotor activity in the open field test in mice. It inhibits cocaine self-administration in rats when administered at doses of 3 or 10 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation. ACS Med. Chem. Lett. 3(7), 544-549 (2012).
2. A novel mGluR5 antagonist, MFZ 10-